| The natural history of chronic allograft nephropathy BJ Nankivell, RJ Borrows, CLS Fung, PJ O'Connell, RDM Allen, ... New England Journal of Medicine 349 (24), 2326-2333, 2003 | 2475 | 2003 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2138* | 2021 |
| Playing the end game: DNA double-strand break repair pathway choice JR Chapman, MRG Taylor, SJ Boulton Molecular cell 47 (4), 497-510, 2012 | 1949 | 2012 |
| The DNA sequence of the human X chromosome MT Ross, DV Grafham, AJ Coffey, S Scherer, K McLay, D Muzny, ... Nature 434 (7031), 325-337, 2005 | 1408 | 2005 |
| Cancer incidence before and after kidney transplantation CM Vajdic, SP McDonald, MRE McCredie, MT Van Leeuwen, JH Stewart, ... Jama 296 (23), 2823-2831, 2006 | 1305 | 2006 |
| KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary BL Kasiske, MG Zeier, JR Chapman, JC Craig, H Ekberg, CA Garvey, ... Kidney international 77 (4), 299-311, 2010 | 997 | 2010 |
| Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation BD Tait, C Süsal, HM Gebel, PW Nickerson, AA Zachary, FHJ Claas, ... Transplantation 95 (1), 19-47, 2013 | 870 | 2013 |
| Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data AC Webster, RC Woodroffe, RS Taylor, JR Chapman, JC Craig Bmj 331 (7520), 810, 2005 | 809 | 2005 |
| RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection JR Chapman, P Barral, JB Vannier, V Borel, M Steger, A Tomas-Loba, ... Molecular cell 49 (5), 858-871, 2013 | 756 | 2013 |
| Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis JS Ried, J Li, XB Zuo, XD Zheng, XY Yin, LD Sun, MA McAleer, ... Nature genetics 47 (12), 1449-1456, 2015 | 629 | 2015 |
| Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology BJ Nankivell, RJ Borrows, CLS Fung, PJ O'Connell, JR Chapman, ... Transplantation 78 (4), 557-565, 2004 | 609 | 2004 |
| REV7 counteracts DNA double-strand break resection and affects PARP inhibition G Xu, JR Chapman, I Brandsma, J Yuan, M Mistrik, P Bouwman, ... Nature 521 (7553), 541-544, 2015 | 607 | 2015 |
| Chronic renal allograft dysfunction JR Chapman, PJ O’Connell, BJ Nankivell Journal of the American society of nephrology 16 (10), 3015-3026, 2005 | 594 | 2005 |
| The DNA sequence and analysis of human chromosome 6 AJ Mungall, SA Palmer, SK Sims, CA Edwards, JL Ashurst, L Wilming, ... Nature 425 (6960), 805-811, 2003 | 537 | 2003 |
| A quantitative review of heterozygosity–fitness correlations in animal populations JR Chapman, S Nakagawa, DW Coltman, J Slate, BC Sheldon Molecular ecology 18 (13), 2746-2765, 2009 | 535 | 2009 |
| Quality heterostructures from two-dimensional crystals unstable in air by their assembly in inert atmosphere Y Cao, A Mishchenko, GL Yu, E Khestanova, AP Rooney, E Prestat, ... Nano letters 15 (8), 4914-4921, 2015 | 513 | 2015 |
| The global role of kidney transplantation GG Garcia, P Harden, J Chapman The Lancet 379 (9820), e36-e38, 2012 | 473 | 2012 |
| The DNA sequence and biological annotation of human chromosome 1 SG Gregory, KF Barlow, KE McLay, R Kaul, D Swarbreck, A Dunham, ... Nature 441 (7091), 315-321, 2006 | 471 | 2006 |
| Chronic allograft nephropathy: current concepts and future directions BJ Nankivell, JR Chapman Transplantation 81 (5), 643-654, 2006 | 464 | 2006 |
| Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials AC Webster, VWS Lee, JR Chapman, JC Craig Transplantation 81 (9), 1234-1248, 2006 | 431 | 2006 |
